Table S5. GeneAnalytics program mapping of diseases with 10 highest match scores for 169 DEGs in TAMG and NMG.
Disease | Genes matched to disease type | No. of genes in disease type | Score |
---|---|---|---|
Lung cancer | KRT14, KRT17, SFTPC, SFTPD, VEGFD, ATM, NAPSA, NMB, SCGB1A1, DSC3, SFTPA2, BNC1, BTNL9, CAB39L, LRRN3, SFTPB | 16 | 9.81 |
Pulmonary fibrosis, idiopathic | SFTPA2, SFTPA1, SFTPC, CCR7, SCGB1A1, SFTPB, SFTPD | 7 | 8.80 |
Breast cancer | ATM, KRT14, KRT17, CYP19A1, TWIST1, VEGFD, AMDHD1, BBOX1, DSC3, IRX1, KCNIP3, LAMP5, MAP2, SCUBE1, TCEAL2 | 15 | 8.33 |
Polycystic kidney disease | BBOX1, CYP4F3, DPEP1, IGFBP6, PRRX1, ADAMTS15, AMDHD1, CNKSR2, LAMP5, MAP1B, MYL9, NAPSA, TWIST1 | 13 | 7.22 |
Neuroblastoma | CYP21A2, KRT1, CADPS, MAP1B, MAP2, ADM, CADPS2, SNKSR2, EPB41L4B, KIF1A, MYL9, NNAT, RAB3IL1, TCEAL2 | 14 | 7.03 |
Respiratory distress syndrome in premature infants | SFTPB, SFTPC, SFTPA1 | 3 | 6.83 |
Dilated cardiomyopathy | MYH6, CRYAB, DSC2, DTNA, MYBPC2, SYNE1, TWIST1 | 7 | 6.50 |
Lung cancer susceptibility 3 | SCGB1A1, SFTPD, VEGFD, NAPSA, SFTPB, SFTPC, NPTX2, PLXNB3, SFTPA2, VIPR1 | 10 | 6.48 |
Colorectal cancer | DPEP1, ATM, CACNA1G, SYNE1, VEGFD, NEUROD1, CAB39L, CD226, LRRN3, MYL9, TFDP3 | 11 | 6.02 |
Tuberous sclerosis complex | CADPS, CNKSR2, DTNA, PRRX1, CYP4F3, EPB41L4B, LAMP5, NEUROD1, NGEF, OLFM3, SCN2B | 11 | 5.97 |
DEG, differentially expressed gene; NMG, non-myasthenia gravis thymoma; TAMG, thymoma-associated myasthenia gravis.